How Medication for Opioid Use Disorder Saves Lives
Medication for opioid use disorder (MOUD) can lower the risk of relapse and overdose. The HEALing Communities Study (HCS) recently launched its fourth campaign, Stay In MOUD Treatment, to highlight the life-saving power of staying on medication for opioid use disorder.
Christina Aivadyan was awarded an F31, and Drs. Kristi Stringer and Brandy Henry achieved tenure-track positions.
Introducing a new research study Intersectional Stigma, HIV, & ART (ISHA), led by Dr. Andrea Norcini Pala, with mentorship by SIG’s Director Dr. Nabila El-Bassel.
Three new publications share research on COVID & policy development, racial disparities in non-emergency care, and the impact of the COVID-19 lockdown on people who use drugs by analyzing social media posts on Reddit.
The Bridge Project finalized its study based at 24 needle exchange programs in Kazakhstan, where 70 care providers were trained to link individuals at each program site to HIV care.
Medication for opioid use disorder (MOUD) can lower the risk of relapse and overdose. The HEALing Communities Study (HCS) recently launched its fourth campaign, Stay In MOUD Treatment, to highlight the life-saving power of staying on medication for opioid use disorder.